 CM Life Sciences, Inc. is a life-sciences-focused special purpose acquisition company founded in July 2020 aiming to deploy 443M in raised cash to acquire a private company. CM LS selected their target, Sema4, a revenue-producing 20: 190M38 CAGR health intelligence company with 1K employees aiming to advance healthcare via a suite of next-gen diagnostics utilizing data-driven platform-insights. 